Atlas Trials

Study of Desvenlafaxine in Treating Major Depressive Disorder.

Clinical trial NCT04364997 · COMPLETED

Trial details

NCT number
NCT04364997
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2020-06-18
Primary completion
2021-09-22
Enrollment
420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.